摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(R)-2,3-bis{(1-oxohexadecyl)oxy}propyloxy](2-cyanoethoxy)(diisopropylamino)phosphane | 183429-86-9

中文名称
——
中文别名
——
英文名称
[(R)-2,3-bis{(1-oxohexadecyl)oxy}propyloxy](2-cyanoethoxy)(diisopropylamino)phosphane
英文别名
[(2R)-3-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2-hexadecanoyloxypropyl] hexadecanoate
[(R)-2,3-bis{(1-oxohexadecyl)oxy}propyloxy](2-cyanoethoxy)(diisopropylamino)phosphane化学式
CAS
183429-86-9
化学式
C44H85N2O6P
mdl
——
分子量
769.142
InChiKey
IAZXDQLKIQBGQT-VPANWNFBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    730.9±60.0 °C(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    16
  • 重原子数:
    53
  • 可旋转键数:
    42
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    98.1
  • 氢给体数:
    0
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    [(R)-2,3-bis{(1-oxohexadecyl)oxy}propyloxy](2-cyanoethoxy)(diisopropylamino)phosphane 在 palladium on activated charcoal 四氮唑盐酸氢气 作用下, 以 甲醇乙醇二氯甲烷 为溶剂, 20.0 ℃ 、517.11 kPa 条件下, 反应 13.0h, 生成 6-deoxy-D-myo-inositol-1-(1,2-di-O-palmitoyl-sn-glycero)cyanoethyl phosphate
    参考文献:
    名称:
    Ins(1,4,5)P 3的脱氧磷脂酰肌醇类似物和膦酸酯等排体的合成
    摘要:
    提出了磷脂酰肌醇类似物,6-脱氧Ins 1-(1,2-二-O-棕榈酰基-sn-甘油)磷酸酯和4,5-双磷酸酯衍生物的合成。-两个系列膦酸酯等排物的,6-脱氧项(1)和-butylphosphonate 6-脱氧项(1)ç还制备-methylenephosphonate以及其4,5-二磷酸类似物。所有磷酸肌醇类似物均获自衍生自d-半乳糖的环己酮多元醇。在PtdIns和InsP衍生物的1位上改变电荷分布,通过用烷基取代基或PC键取代POH基团,可抵抗脂肪酶的裂解,可以在酶的进一步策略性酶水平上抑制活性。肌苷级联。
    DOI:
    10.1016/s0040-4020(99)00793-0
  • 作为产物:
    描述:
    (+)-3-O-(4-methoxybenzyl)-1,2-di-O-hexadecanoyl-sn-glycerol 在 palladium on activated charcoal 四氮唑氢气 作用下, 以 乙醇二氯甲烷溶剂黄146 为溶剂, 反应 3.67h, 生成 [(R)-2,3-bis{(1-oxohexadecyl)oxy}propyloxy](2-cyanoethoxy)(diisopropylamino)phosphane
    参考文献:
    名称:
    Synthesis of Phosphotriester Analogues of the Phosphoinositides PtdIns(4,5)P2 and PtdIns(3,4,5)P3
    摘要:
    A synthetic route was developed for the preparation of novel O-(3-aminopropyl) tethered phosphotriester analogs (5) of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5,)P-2, or PIP2) and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3, or PIP3) using the coupling reagent 2-cyanoethyl N,N,N',N'-tetraisopropylphosphorodiamidite. The phosphotriester ligand design introduced a reactive aminopropyl group at the polar lipid head of the ring-phosphorylated phosphoinositides, allowing a reporter moiety to be positioned at the surface of the bilayer and in the vicinity of the phosphorylated inositol. Such reporter groups may interact with membrane-proximal regions of PIP2- and PIP3-binding proteins recruited to membrane sites by electrostatic interactions between the phosphates of the phospholipid and basic regions of the proteins. Following a convergent strategy, phosphitylation of an optically-pure 1,2-O-diacyl-sn-glycerol with 2-cyanoethyl N,N,N',N'-tetraisopropylphosphorodiamidite was followed by coupling with protected inositol precursors to give adducts 8 in 80% to 95% yield. The 2-cyanoethyl phosphotriester was stable during the subsequent reaction steps and could be conveniently converted to the 3-aminopropyl group during the final hydrogenolysis of the benzyl protecting groups. Benzophenone-containing photoaffinity probes of the phosphotriester IIa and IIb were also synthesized. Alternatively, the versatile cyanoethyl group could be removed using diisopropylethylamine prior to hydrogenolysis, thereby furnishing the corresponding phosphodiesters, PIP3 and PIP2 (13a and 13b).
    DOI:
    10.1021/jo961226g
点击查看最新优质反应信息

文献信息

  • Synthesis Of Labeled Glycosyl Phosphatidyl Inositol (GPI) Anchors
    作者:Thomas G. Mayer、Ralf Weingart、Florian Münstermann、Toshinari Kawada、Teymuras Kurzchalia、Richard R. Schmidt
    DOI:10.1002/(sici)1099-0690(199910)1999:10<2563::aid-ejoc2563>3.0.co;2-i
    日期:1999.10
    sorting of GPI-anchored proteins is based on labeled partial structures of GPI′s which can be incorporated into the GPI anchor biosynthesis and cellular transport systems. To this end, from mannosyl donor 6 and the D-glucosaminyl-(16)-D-myo-inositol derivative 7 as acceptor, the pseudotrisaccharide 8 was prepared. Compound 8 was transformed into the GPI partial structures 5a,b which contain the pseudotrisaccharide
    对 GPI 锚定蛋白分选的分子和结构基础的探索是基于 GPI 的标记部分结构,这些结构可以整合到 GPI 锚定生物合成和细胞转运系统中。为此,从甘露糖基供体6和作为受体的D-葡糖胺基-(16)-D-肌醇衍生物7制备假三糖8。将化合物 8 转化为 GPI 部分结构 5a、b,其中包含与两个不同磷脂酰残基连接的假三糖。化合物5a、b在葡糖胺残基的2-氨基(2b-位)处具有Boc保护,在6b-位处具有游离氨基。6b-氨基用于连接 3-(7-nitrobenzofurazan-4-yl)-aminopropanoyl 基团作为荧光标记,5-叠氮基-2-硝基苯甲酰基和4-叠氮基苯基氨基硫代羰基作为光标记,4-叠氮基-2-羟基苯甲酰基通过亲电芳香取代引入放射性碘后作为放射性标记。因此,在酸催化去除保护基团后,得到未保护的目标分子 1-4。
  • Chemical Synthesis and Molecular Recognition of Phosphatase-Resistant Analogues of Phosphatidylinositol-3-phosphate
    作者:Yong Xu、Stephanie A. Lee、Tatiana G. Kutateladze、Diego Sbrissa、Assia Shisheva、Glenn D. Prestwich
    DOI:10.1021/ja0554716
    日期:2006.1.1
    stabilized (ms) analogues of phosphatidylinositol-3-phosphate (PtdIns(3)P) were synthesized. We describe herein the total asymmetric synthesis of 3-methylphosphonate, 3-(monofluoromethyl)phosphonate and 3-phosphorothioate analogues of PtdIns(3)P. From differentially protected D-myo-inositol key intermediates, a versatile phosphoramidite reagent was employed in the synthesis of PtdIns(3)P analogues with diacylglyceryl
    磷酸酶和激酶对细胞膜中磷脂酰肌醇多磷酸酯的重塑在空间和时间上协调了这些脂质的信号传导。为了提供化学工具来研究由这些脂质介导的细胞生理学的变化,合成了三种新的代谢稳定 (ms) 磷脂酰肌醇 3-磷酸 (PtdIns(3)P) 类似物。我们在此描述了 PtdIns(3)P 的 3-甲基膦酸酯、3-(单氟甲基)膦酸酯和 3-硫代磷酸酯类似物的全不对称合成。从差异保护的 D-肌醇关键中间体,一种多功能亚磷酰胺试剂用于合成 PtdIns(3)P 类似物,其二酰基甘油基部分包含二油酰基、二棕榈酰基和二丁酰基链。此外,我们引入了一种新的磷酸化试剂,(单氟甲基)膦酰氯,它具有制备“pKa 匹配”单氟膦酸盐的一般应用。这些 ms-PtdIns(3)P 类似物与 15N 标记的 FYVE 和 PX 结构域的结合活性降低,因为 FYVE 结构域中显着的 1H 和 15N 化学位移变化是通过将 ms-PtdIns(3)P
  • Phospholipidation of TLR7/8-active imidazoquinolines using a tandem phosphoramidite method
    作者:Hélène G. Bazin、Laura S. Bess、Mark T. Livesay、Sandra C. Mwakwari、David A. Johnson
    DOI:10.1016/j.tetlet.2016.03.091
    日期:2016.5
    1-imidazoquinolinylalkanols. The resulting phosphite can be purified or directly oxidized with t-butyl hydroperoxide. The cyanoethyl protecting group is then removed with triethylamine and the phospholipidated imidazoquinoline products isolated in good yield and purity by simple filtration.
    开发了一种高产且可扩展的亚磷酰胺工艺,用于 TLR7/8 活性咪唑并喹啉的磷脂化。该方法涉及1,2-二酰基-或二烷基-sn-甘油或3-氯甾醇与2-氰基乙基N , N , N ', N'-四异丙基亚磷二酰胺在1H-四唑存在下反应,然后用所得的N , N'-二异丙基亚磷酰胺脂质与 1-咪唑并喹啉基链烷醇原位反应。所得亚磷酸酯可以纯化或直接用叔丁基过氧化氢氧化。然后用三乙胺除去氰乙基保护基团,并通过简单的过滤以良好的产率和纯度分离磷脂化的咪唑喹啉产物。
  • 5-Stabilized Phosphatidylinositol 3,4,5-Trisphosphate Analogues Bind Grp1 PH, Inhibit Phosphoinositide Phosphatases, and Block Neutrophil Migration
    作者:Honglu Zhang、Ju He、Tatiana G. Kutateladze、Takahiro Sakai、Takehiko Sasaki、Nicolas Markadieu、Christophe Erneux、Glenn D. Prestwich
    DOI:10.1002/cbic.200900545
    日期:2010.2.15
    Four ways to work: Two 5‐phosphatase resistant analogues of PtdIns(3,4,5)P3, the 5‐methylene phosphonate (MP) and 5‐phosphorothioate (PT) were synthesized and evaluated in four biochemical and biological contexts. Analogues were resistant to 5‐phosphatase activity of SHIP, bound to the PH domain of Grp1, blocked neutrophil migration, and activated sodium transport.
    四种工作方式:合成了 PtdIns(3,4,5)P 3 的两种 5-磷酸酶抗性类似物、5-亚甲基膦酸酯 (MP) 和 5-硫代磷酸酯 (PT),并在四种生化和生物学背景下进行了评估。类似物对 SHIP 的 5-磷酸酶活性具有抗性,与 Grp1 的 PH 结构域结合,阻止中性粒细胞迁移并激活钠转运。
  • [EN] PHOSPHOLIPIDATION OF IMIDAZOQUINOLINES AND OXOADENINES<br/>[FR] PHOSPHOLIPIDATION D'IMIDAZOQUINOLINES ET D'OXOADÉNINES
    申请人:GLAXOSMITHKLINE BIOLOGICALS SA
    公开号:WO2017102654A1
    公开(公告)日:2017-06-22
    The present invention relates to a process for phospholipidation of imidazoquinolines and oxoadenines. More particularly, the present invention relates to a high-yielding and scalable procedure for the phospholipidation of imidazoquinolines and oxoadenines which obviates the need to isolate unstable phosphoramidite intermediates. This process may be used for the phospholipidation of toll-like receptor 7 (TLR7) - active and toll-like receptor (TLR8) -active imidazoquinolines and oxoadenines.
    本发明涉及一种对咪唑喹啉和氧代腺嘌呤进行磷脂化的方法。更具体地说,本发明涉及一种高产率和可扩展的咪唑喹啉和氧代腺嘌呤磷脂化过程,避免了需要分离不稳定的磷酸酰胺中间体的需要。该过程可用于对Toll样受体7(TLR7)活性和Toll样受体8(TLR8)活性的咪唑喹啉和氧代腺嘌呤进行磷脂化。
查看更多